AXT Inc (AXTI)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-09
$68.91-0.93%
Close 2026-09-09 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-09
Intact: The reason to own it still holds.
AXT grew revenue from $23.0M in 2025-Q4 to $26.9M in 2026-Q1. The company secured a long-term supply agreement supporting future sales. Recent earnings beats show improving execution. New board members add governance strength.
AXT is still loss-making with negative free cash flow. The stock has sold off sharply, down 58.7% from its high. Revenue growth and profitability remain uncertain. Analyst revisions have been mostly downward recently.
The price is about 23% below our fair value near $76. Analysts expect 76% revenue growth next year. Our fair value is 17% below the Street median, reflecting caution on profitability and execution risks.
Breaks if: Material breach or cancellation of supply agreement
Breaks if: EPS remains negative or below $0.1 in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround play, as AXTI is working to improve its operational performance while facing high risks. The current thesis state indicates cautious optimism, given recent financial improvements but ongoing volatility in management and market conditions.
The market seems to have priced in a stretched valuation compared to peers, reflecting some optimism about future growth potential. However, there is a low fragility tier, suggesting that current expectations may not be overly aggressive.
Fundamentals are likely to show continued revenue growth driven by indium phosphide demand, as management is on track with its priorities. However, the company remains loss-making, and recent earnings surprises have been trending down, indicating potential challenges ahead.
The long-term thesis hinges on management's ability to execute on capacity expansion and revenue growth while navigating external market conditions. Key factors include guidance updates from management and performance of sector leaders like NVDA and TSM, as well as potential interest rate changes from the Fed.
The most important moves since the prior daily snapshot.
Valuation fell by 10.2 points (from 35.6 to 25.4).
Yes, our read has weakened. The recent sharp drop in AXTI's stock price suggests a repricing of the thesis. This follows a significant decline of 17% in a single session. However, the latest earnings beat and partnerships to expand indium phosphide capacity support the company's outlook.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Revenue falls below $23M in any quarter after 2026-Q1
AXTI is in a delicate recovery phase with mixed management execution and market dynamics. Not investment advice.